A-Alpha Bio and Livermore Lab Expand ML Collaboration on Antibody Discovery and Biothreats

SEATTLE, May 16, 2023 — A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, and Lawrence Livermore National Laboratory (LLNL) today announced a collaboration to combat multiple pathogen families of concern. To enable this work, A-Alpha Bio has been awarded an additional $2.4 million sub-contract from the Joint Program Executive […]